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Introduction
Acromegaly is a chronic disease caused by growth hormone
(GH) excess due to a GH-secreting pituitary adenoma inmost
cases.1 It is associated with an increase in mortality and
morbidity, especially due to cardiovascular complications.2
Among other consequences, it is characterized by the over-
growth of bone, including the skull and soft tissues.
Although usually presenting an indolent, slow evolution,
diagnosed 5 years after the ﬁrst signs of acromegaly, cardio-
vascular and metabolic comorbidities are accompanied with
an increased mortality in untreated patients. Without an
appropriate therapy, the life of patients with acromegaly can
beshortenedby tenyears. Before thecurrent therapiesbecame
available, the standard mortality rate for these patients was
reported tobeof2–3years. However, in somestudies thereare
meta-analyses reportingmortality rates similar to those of the
general population inpatientswithnormalGHafter successful
therapy, and even normal insulin-like growth factor 1 (IGF-1).
Using sensitive assays, the cut-off level for “safe” GH is still a
matter of debate, but a recent consensus suggested it could be
of 1 ng/mL.3,4
Pituitary adenomas are common benign monoclonal neo-
plasms accounting for  15% of intracranial neoplasms. Some
pituitary adenomas (mainly microadenomas that have a dia-
meter of less than 1 cm) are exceedingly common, and are
incidentally diagnosed on magnetic resonance imaging (MRI)
performed for an unrelated reason (headache, vertigo, head
trauma). Most microadenomas remain clinically occult and
stable in size, without an increase in tumor cells, and without
local mass effects. However, some pituitary adenomas grow
slowly, enlarged by expansion, and become demarcated on the
normal pituitary gland (macroadenomas have a diameter
greater than 1 cm). They may be clinically silent or secrete
anterior pituitary hormones in excess, such as prolactin, GH, or






Abstract Introduction Acromegaly is a chronic disease caused by growth hormone (GH) excess
due to a GH-secreting pituitary adenoma in most cases. There is reasonable data to
presume the possible inﬂuence of chronic GH and insulin-like growth factor I (IGF-I)
hyperproduction on the anatomical structures involved in normal sound perception,
and on its conductive and/or sensorineural part.
Objectives To review the literature about acromegaly and hearing loss.
Data Synthesis A systematic literature search was performed using the MEDLINE
database, including hand-searching reference lists from original articles. The search
was performed using the terms hearing loss and acromegaly, and only 5 studies were
found.
Conclusion The results are not consistent, but led to different conclusions. Therefore,
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involving the thyroid-stimulating hormone (TSH) or gonado-
tropins (luteinizing hormone [LH], follicle-stimulating hor-
mone [FSH]).5
There is reasonable data to presume the possible inﬂuence
of chronic GH and IGF-1 hyperproduction on the anatomical
structures involved in normal sound perception, and on its
conductive and/or sensorineural part.3 Additionally, there is a
possibility of inferior pituitary tumor invasion of the epiphar-
ynxwith impact on the Eustachian tubes. Although it received
some attention in the past, this problem has not been inves-
tigated frequently.
Deafness, in all of its forms, affects 1 in every 1,000 new-
borns in the United States, and progressively afﬂicts larger
numbers of individualswith advancing age. Somestudies have
described that by the age of 60, 1 out of every 3 individuals in
the United States experiences communication difﬁculties as a
consequence ofhearing loss, and by 85 years of age, half of the
populationhas somedegree ofhearingdisability. Signiﬁcantly,
most peripheral auditory diseases involve some form of
cochlear abnormality that disrupts sensory transduction.
The varietyof conditions that produce suchdisabilities include
genetic abnormalities, trauma (acoustic and mechanical),
ototoxicagents,bacterial andviral infections,anddisturbances
in other organ systems that inﬂuence cochlear physiology
indirectly.4,5
Acromegaly-related soft tissue expansion and bone hyper-
trophy are thought to cause ear problems; however, such an
association has yet to be conﬁrmed. Graham and Brackmann
observedhypertrophyof themastoid cortical boneandposter-
ior bonywall in three patientswith acromegaly duringmiddle
ear surgery.6
Little is known about hearing loss in patients with acro-
megaly. As it is a scarcely studied subject, it is important to
start investigating it. Thebest way to do it would be to go over
everything on the subject, in order to get ideas about it.
Due to the impact of deafness in society, and to the
supposed pathophysiological relationship that can exist
between acromegaly and hearing loss, we performed a review
of the literature on this subject.
Review of Literature
The search strategy employed in this literature review was
guided by the combination of two descriptors indexed in the
Medical Subject Headings (MeSH): acromegaly and hearing
loss. Therefore, we performed a systematic review using the
same descriptors in the PubMed library, and analyzed all
articles published. The last manual search conducted in
electronic databases occurred in July 2016.
The entire search process, the selection of articles, and
data extractionwere conducted in pairs. After the search, the
articles were selected based on their titles and abstracts.
Subsequently, the texts of all selected articles were obtained
in full.
A systematic literature search was performed usingMED-
LINE database, including hand-searching reference lists from
original articles. We identiﬁed ﬁve studies.
Each study was reviewed by two separate authors (L.S.T
and I.B.O),who independently screened abstracts and titles
using the following inclusion criteria: 1) the articles had to be
written in English; and 2) they had to be studies on acro-
megaly and hearing loss. The exclusion criteria were: 1)
articles not written in English; and 2) studies that did not
correlate hearing loss with acromegaly.
The relevant data for each article found are listed
in ►Table 1. The evaluated items included author and origin,
number of patients (N), journal, study design, and subject.
►Table 2 shows the type of hearing loss (conductive, sensor-
ineural or mixed) found in the articles, and the percentage of
each one. A complete analysis of the articles was performed,
Table 1 Characterization of the Studies
Author and origin N Journal Study design Subject
Doig and Gatehouse7
USA
56 The Journal of Laryngology
& Otology, v. 98, 1984
Transversal Comparison of the audiometry and clinic
examinations of an acromegaly group
and a control one
Carvalho et al8
Brazil
34 Brazilian Journal of
Otorhinolaryngology,
v. 78, 2012
Cross-sectional A metabolic evaluation, tonal audiometry
and brainstem auditory evoked potential





Transversal Pure tone audiometry, speech audiometry,
tympanometry, otoacoustic emissions
testing, computed tomography of the
temporal bone and magnetic resonance
imaging of the ear performed in
acromegalic and healthy patients.
Graham and Brackmann9
USA
3 The Journal of Laryngology
& Otology, v. 92, 1978
Series of
cases




30 Otology & Neurotology,
v. 27, 2006
Prospective A prospective study in a tertiary referral
center, because of rare conﬂicting results
reported concerning a possible higher
frequency of hearing loss in acromegalic
patients.
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and encountered computed tomography (CT) ﬁndings in only
two of them, as shown in ►Table 3.
Discussion
Doig and Gatehouse (1978)7 evaluated 56 patients with
acromegaly through audiometry and clinical examinations.
Those patients were compared with a healthy control group.
In this study, there were no signiﬁcant differences between
the case and control groups in terms of the audiometric
evaluation.
Carvalho et al (2012)8 conducted the ﬁrst study in
acromegalic patients inwhich the evaluationwas performed
with auditory brainstem response besides audiometry. This
exam is more objective, and, therefore, allows for a more
reliable analysis. In this study, only sensorineural hearing
loss (SNHL) was found (35.3%), and it was most prevalent in
higher frequencies and bilaterally. The researchers noticed
that lower levels of GH and IGF-1 were found in higher
prevalence in patients with hearing loss, but there was no
signiﬁcant association between these variables, or between
hearing loss and the clinical parameters.
The present study may have been the ﬁrst to make the
comparisonmodel of the brainstem auditory evoked potential
among acromegalic patients with and without SNHL.
Aydin et al (2012)6 conducted a study to proﬁle the
audiological and structural function in patients with acrome-
galy. The evaluated group was composed of 44 patients with
acromegaly and 36 healthy patients. All of the patients under-
went a CT of the mastoids, an MRI of the inner ear, tonal and
vocal audiometries and impedancemetry. A clinical research
focused on auditory symptoms was also conducted. The
patients with acromegaly were divided into 3 groups: those
who had controlled the disease, those who had partially
controlled it, and those with uncontrolled diseases. From the
viewpoint of the structure, the signiﬁcant ﬁnding was the
presence of degeneration of the temporomandibular joint. In
this study, three types of hearing loss were found: conductive,
sensorineural and mixed. The elevated hearing thresholds in
the patientswith acromegalywere not correlatedwith disease
activity in this study, suggesting that acromegaly –whether or
not controlled – caused hearing loss.
This study shows that acromegaly is commonly associated
with heterogeneous ear problems.6
Graham and Brackmann (1978)9 reviewed 3 patients
with acromegaly and clinical characteristics. In all patients,
the gross clinical features of acromegaly were present, and
considerable difﬁculty was encountered in clearly demon-
strating the radiographic features of the temporal bone due
tomarked bone hypertrophy. However, the internal auditory
canal, the cochlea and the vestibule appeared normal. Prior
to the surgical intervention, whether or not the facial nerve
would be in the normal position due to excessive bone
overgrowth was initially a considerable concern. However,
in spite of amassivemastoid cortex bone andgenerally heavy
posterior bony canal wall with secondary lengthening of the
Table 2 Hearing loss characterization in acromegalic patients
Author Type of Hearing Loss Percentage of Hearing Loss
Doig and Gatehouse7 Conductive hearing loss There is no signiﬁcant
difference between the air-bone
gaps in the acromegalic patients
and those of the controls
Carvalho et al8 Sensorineural hearing loss: 8 bilateral and 4 unilateral. 38.9%
Aydin et al6 Conductive, sensorineural and mixed hearing
losses in at least one ear
9%; 30%, 18%
Graham and Brackmann9 Case 1: ﬁndings typical of Meniere’s disease
Case 2: cholesteatoma with a 40 dB conductive hearing loss
Case 3: recurrent episodes of purulent drainage
33%, 33%, 33%
Babic et al10 Conductive hearing loss; middle ear ventilation problem 23%
Table 3 Computed Tomography Findings
Author Computed tomography findings
Doig and Gatehouse7 No CT results
Carvalho et al8 No CT results
Aydin et al6 Auditory imaging showed that 50% of the patients had temporomandibular joint degeneration.
The most common abnormality in the patients with acromegaly was mastoid sclerosis.
Graham and Brackmann9 In all three patients, considerable difﬁculty was encountered in clearly demonstrating the
radiographic features of the temporal bone due to marked bone hypertrophy. However,
in all patients, the internal auditory canal, the cochlea and the vestibule appeared normal.
Babic et al10 No CT results
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bony external auditory canal, the structures of the otic
capsule, horizontal semicircular canal, oval window, round
window, and facial nerve were in perfectly normal relation-
ships. Surgery performed on two patients conﬁrmed these
ﬁndings. Despite the small number of patients in the study, it
was very important to evaluate the temporal bone altera-
tions that may occur in patients with acromegaly.
Babic et al (2006)10 performed a prospective study in a
tertiary referral center because of rare conﬂicting results
reported concerning a possible higher frequency of hearing
loss in acromegalic patients. The goal was to determine
whether there is a higher frequency of conductive hearing
loss in acromegalic patients. Thirty previously untreated
patients with acromegaly were compared with 20 age- and
sex-matched healthy control subjects. The interventions in all
subjects included: otomicroscopy, tuning fork tests, audiome-
try, tympanometry, cochleostapedial reﬂex, and otoacoustic
emissions. In the acromegalic patients, endocrinological
assessments, MRIs, and, if necessary, epipharyngoscopies
were performed. The only statistically signiﬁcant difference
between the untreated acromegalic patients and the healthy
subjectswas the presence ofmiddle ear ventilationproblem: it
occurred in 7/30 acromegalic patients (23%), and innoneof the
20 healthy controls (0%), p ¼ 0.033. The acromegalic patients
with middle ear ventilation problem were signiﬁcantly older,
with diseases of longer duration, andwith lowermean growth
hormone (GH) levels in comparison with the acromegalic
patients without this problem.
Opinions concerning the presence of conductive hearing
loss in acromegaly in the literature are contradictory. There-
fore, this study has the goal of investigating possible con-
ductive hearing disturbances in acromegalic patients.
Issues as to the real cause-and-effect relationship between
acromegaly and hearing loss require longitudinal studies.
However, because of the rarity of this disease, we cannot
expect to have studies with larger groups of individuals.
Final Comments
According to the literature discussed, we can infer that there
are no consistent results, and that they lead to different
conclusions. This probably occurred due to the signiﬁcant
prevalence of hearing loss in the world, which would require
a larger amount of acromegaly patients to be studied.
We conclude that a study with a greater number of
patients with acromegaly is needed to achieve more con-
ﬁdent results.
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